SCHEER Final Opinion on the safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL)

Following a request from the European Commission, the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) provided a Final Opinion on the safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL). 

Overall SCHEER considers that there is a moderate weight of evidence for a causal relationship between textured breast implants and ALCL, particularly in relation to implants with an intermediate to high surface roughness. In addition, SCHEER recognises that there are several types of textured implants, that surface textures of breast implants are not all manufactured in the same way, and that implants with diverse surface textures may also present different benefits.

CONTINUE READING ON ec.europa.eu